Home » Topics » Regulatory » Patents

Patents
RSS

Novel, irreversible HIV protease inhibitor disclosed by LG Chemical

July 2, 1997

Roche describes endothelin antagonists

July 2, 1997

Kyowa Hakko discovers inhibitors of IL-1beta production

July 2, 1997

ET antagonists claimed by Bristol-Myers Squibb

July 2, 1997

Potent and selective dopamine D3 ligands from ADIR

July 2, 1997

Synthelabo reveals 5-HT4/5-HT3 receptor ligands

June 30, 1997

Novel progestins/antiprogestins disclosed by Ortho

June 30, 1997

ET antagonists disclosed by Roussel Uclaf

June 30, 1997

Inhibitors of MHC class II binding from Merck & Co.

June 30, 1997

Ajinomoto prepares peptides for treating or preventing human gastric cancer

June 30, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...